Current clinical and preclinical evidence indicates that PRP and mesenchymal stem cell (MSC) injections can help manage spinal disc degeneration and associated pain by promoting tissue regeneration and reducing inflammation.
The retrieved literature consistently supports the therapeutic utility of PRP and MSC injections for treating intervertebral disc degeneration. Animal studies, systematic reviews, and clinical evaluations report improvements in pain scores, tissue healing, and structural restoration, supporting the claim without significant contradicting evidence in the provided set.